Marketers have a few more tools in their battle to win over audiences.

Mobile ad-technology company Fiksu is introducing a pair of new products as parts of its marketing platform. These includes Fiksu Aware and Fiksu Response, which are both fully integrated into the company’s other tools. Aware enables brands to find precise audiences on smartphones and tablets. Response helps companies convert audiences into paying customers. Mobile advertising generated around $18 billion in 2014, and apps were a big part of that.

In a statement, Fiksu chief executive officer Micah Adler said that the company came up with these products as a response to the “maturation of mobile.” Adler went on to say that smartphones and tablets represent “the dominant form of digital interaction for consumers worldwide.”

Aware and Response both fit into Fiksu’s mIQ platform, which uses a database of “2 billion mobile device profiles.” This tool enables marketers to have full control over a campaign while simultaneously providing the data needed to get the best return on their investment.

“Global marketers need a single solution rooted in mobile,” said Adler.

Fiksu’s competitors include 4info and Taptica.

In addition to the new tools, Fiksu is also launching a new logo, which you can check out below:

Fiksu_Registered_Logo_CMYK

Get more stories like this on TwitterFacebook

The Fiksu Indexes, which measure monthly fluctuations in competition for rank in the app stores, and the cost to acquire loyal users(1), help mobile app marketers benchmark their performance... All Fiksu news »

Track Fiksu's Landscape to stay on top of the industry. Access the entire ecosystem, track innovation & deals. Learn more.

An academic turned prolific technology entrepreneur, Micah Adler combines rich industry insight with complex technical knowledge as the president, CEO, and founder of Fiksu. Previously, Mica... All Micah Adler news »

Track Micah Adler's Landscape to stay on top of the industry. Access the entire ecosystem, track innovation & deals. Learn more.